Brief: Bioventus Reports Preliminary Q1 Net Sales, Adjusted EBITDA
April 26 (Reuters) - Bioventus Inc BVS.O :
* BIOVENTUS ANNOUNCES PRELIMINARY FIRST QUARTER NET SALES
AND
ADJUSTED EBITDA
* PRELIMINARY, UNAUDITED NET SALES FOR Q1 OF 2022 IS
EXPECTED TO
BE IN RANGE OF $116.5 MILLION TO $118.5 MILLION
* Q1 REVENUE VIEW $117.8 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2lDQcx
Further company coverage: BVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioventus
See all newsBioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Bioventus rises after better-than-expected quarterly results